NIH-funded research R01 grant

Understanding how changes in DNA structure affect treatment outcomes in children with leukemia

Official title: Remodeling of 3D chromatin in B cell acute leukemia and its impact on clinical outcome

Funded at New York University School of Medicine · NIH-11082275 · Data updated 2026-11-12

This study is looking at how changes in the way DNA is organized can affect how well treatments work for kids with B cell acute leukemia, with the hope of finding better ways to help them feel better.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York University School of Medicine
NIH-funded
Lab location1 site (New York, United States)
Project startApril 1, 2021
Project endMarch 31, 2026
Funding year2025
Award (this year)$430,442
NIH project number5R01CA260028-05
Project IDNIH-11082275 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children diagnosed with acute lymphoblastic leukemia, particularly those who may not be responding well to current therapies.

Less likely to help

Patients with other types of leukemia or those who are not diagnosed with acute lymphoblastic leukemia may not benefit from this research.

What this research studies

This research investigates the role of chromatin remodeling in B cell acute leukemia, particularly focusing on how changes in DNA structure can influence treatment responses and clinical outcomes. By utilizing advanced techniques to analyze the organization of chromatin, the study aims to uncover the mechanisms behind leukemia initiation and resistance to therapy. The findings could lead to the development of more targeted and effective therapies for children suffering from this condition.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment strategies that are more effective and less burdensome for children with acute lymphoblastic leukemia.

How similar studies have gone: While the approach of studying chromatin remodeling in leukemia is relatively novel, there have been successful studies in related areas that suggest potential for impactful findings.

Where this research is happening

  • New York University School of Medicine
    New York, United States
    Active

Researchers

  • Principal investigator: Carroll, William L. — New York University School of Medicine
  • Study coordinator: Carroll, William L.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.